相似文献
1
Clinical immunology and multiplex biomarkers of human tuberculosis.
Cold Spring Harb Perspect Med. 2014 Dec 4;5(4):a018515. doi: 10.1101/cshperspect.a018515.
2
[Development of antituberculous drugs: current status and future prospects].
Kekkaku. 2006 Dec;81(12):753-74.
3
[Evolution of IGRA researches].
Kekkaku. 2008 Sep;83(9):641-52.
4
Ten challenges for TB biomarkers.
Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S17-20. doi: 10.1016/S1472-9792(12)70007-0.
5
Enabling biomarkers for tuberculosis control.
Int J Tuberc Lung Dis. 2012 Sep;16(9):1140-8. doi: 10.5588/ijtld.12.0246.
6
Regulation network of serum cytokines induced by tuberculosis-specific antigens reveals biomarkers for tuberculosis diagnosis.
Genet Mol Res. 2015 Dec 17;14(4):17182-92. doi: 10.4238/2015.December.16.18.
7
Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array.
Tuberculosis (Edinb). 2016 Mar;97:108-17. doi: 10.1016/j.tube.2015.12.007. Epub 2016 Jan 14.
8
Molecular approaches and biomarkers for detection of Mycobacterium tuberculosis.
Clin Lab Med. 2013 Sep;33(3):553-66. doi: 10.1016/j.cll.2013.03.012.
9
Proteomics-based host-specific biomarkers for tuberculosis: The future of TB diagnosis.
J Proteomics. 2024 Aug 15;305:105245. doi: 10.1016/j.jprot.2024.105245. Epub 2024 Jun 26.
10
The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease.
Pathog Dis. 2019 Jun 1;77(4). doi: 10.1093/femspd/ftz037.
引用本文的文献
1
COVID-19 and Tuberculosis: Mathematical Modeling of Infection Spread Taking into Account Reduced Screening.
Diagnostics (Basel). 2024 Mar 26;14(7):698. doi: 10.3390/diagnostics14070698.
2
Aptamer-Based Diagnostic Systems for the Rapid Screening of TB at the Point-of-Care.
Diagnostics (Basel). 2021 Jul 28;11(8):1352. doi: 10.3390/diagnostics11081352.
3
Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients.
Front Cell Infect Microbiol. 2021 Jul 9;11:669623. doi: 10.3389/fcimb.2021.669623. eCollection 2021.
4
Validation of Differentially Expressed Immune Biomarkers in Latent and Active Tuberculosis by Real-Time PCR.
Front Immunol. 2021 Mar 16;11:612564. doi: 10.3389/fimmu.2020.612564. eCollection 2020.
5
The meta-analysis for ideal cytokines to distinguish the latent and active TB infection.
BMC Pulm Med. 2020 Sep 18;20(1):248. doi: 10.1186/s12890-020-01280-x.
6
A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children.
EBioMedicine. 2020 Aug;58:102909. doi: 10.1016/j.ebiom.2020.102909. Epub 2020 Jul 22.
7
Is interleukin-2 an optimal marker for diagnosing tuberculosis infection? A systematic review and meta-analysis.
Ann Med. 2020 Nov;52(7):376-385. doi: 10.1080/07853890.2020.1800073. Epub 2020 Jul 30.
8
Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.
J Infect Dis. 2020 Nov 13;222(12):2093-2102. doi: 10.1093/infdis/jiz643.
9
Design and Construction of a Eukaryotic Cloning Vector Encoding the mpt51 Gene of .
Rep Biochem Mol Biol. 2019 Apr;8(1):32-35.
10
Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB.
J Transl Med. 2018 Jul 20;16(1):206. doi: 10.1186/s12967-018-1572-x.
本文引用的文献
1
Toward a unified biosignature for tuberculosis.
Cold Spring Harb Perspect Med. 2014 Oct 23;5(1):a018531. doi: 10.1101/cshperspect.a018531.
2
Diagnosis of childhood tuberculosis and host RNA expression in Africa.
N Engl J Med. 2014 May 1;370(18):1712-1723. doi: 10.1056/NEJMoa1303657.
3
A metabolic biosignature of early response to anti-tuberculosis treatment.
BMC Infect Dis. 2014 Jan 31;14:53. doi: 10.1186/1471-2334-14-53.
4
Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.
PLoS One. 2013 Dec 5;8(12):e81076. doi: 10.1371/journal.pone.0081076. eCollection 2013.
5
miRNA signatures in sera of patients with active pulmonary tuberculosis.
PLoS One. 2013 Nov 21;8(11):e80149. doi: 10.1371/journal.pone.0080149. eCollection 2013.
6
Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity.
Clin Microbiol Infect. 2014 Apr;20(4):O230-8. doi: 10.1111/1469-0691.12383. Epub 2013 Nov 11.
7
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study.
PLoS Med. 2013 Oct;10(10):e1001538. doi: 10.1371/journal.pmed.1001538. Epub 2013 Oct 22.
8
A helicopter perspective on TB biomarkers: pathway and process based analysis of gene expression data provides new insight into TB pathogenesis.
PLoS One. 2013 Sep 16;8(9):e73230. doi: 10.1371/journal.pone.0073230. eCollection 2013.
9
Endemic infections in Southeast Asia provide new insights to the phenotypic spectrum of primary immunodeficiency disorders.
Asian Pac J Allergy Immunol. 2013 Sep;31(3):217-26.
10
T-cell immunophenotyping distinguishes active from latent tuberculosis.
J Infect Dis. 2013 Sep;208(6):952-68. doi: 10.1093/infdis/jit265.
Zotero 插件